The largest database of trusted experimental protocols

6 protocols using pstat3 pe

1

CD14+ Monocyte Profiling of IL-6 Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD14+ monocytes were isolated from HLA-matched donor peripheral blood by flow sorting using CD14-FITC (Becton Dickinson) and Moflo Astrios EQ flow cytometry sorter. Post-sorted cells were incubated in various conditions for 96 hours on ultra-low attachment plates (Corning). 811-conditioned media (811 CM) was collected off 90% confluent 811 cell line and immediately frozen at −80°C for later use. IL6 neutralizing antibody (R& D Systems) was used at concentration of 50µg/ml and tocilizumab (Genentech) was used at concentration of 1mg/ml. Media were harvested from cells after 96 hours and cytokine concentrations were measured by multiplex bead cytokine analysis as described above. Cells were stained with pSTAT3-PE (BD) according to manufacturer’s instructions and run on Beckman Coulter Gallios 561; analysis was done using FlowJo v10.0.7 (FlowJo).
+ Open protocol
+ Expand
2

IL-6 and IL-7 Signaling Pathway Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For each subject, blood samples were collected by venipuncture into 2‐mL sodium heparin tubes before and at 1, 6, and 12 hours after administration of upadacitinib (day 1 in Study 1; days 1 and 14 in Study 2, Part 1; days 3 and 28 of Study 2, Part 2), tofacitinib (days 1 and 14 in Study 2, Part 3), or placebo (day 1 in Study 1; days 1 and 14 in Study 2, Part 1; days 3 and 28 of Study 2, Part 2). The blood samples were frozen and shipped to the AbbVie Bioresearch Center (Worcester, Massachusetts) for processing and analysis. IL‐6–induced pSTAT3 and IL‐7–induced pSTAT5 were assayed as previously described.19 Briefly, recombinant human IL‐6 or IL‐7 (R&D Systems, Minneapolis, Minnesota) was added to blood followed by addition of surface antibodies (CD14‐APC, CD3‐fluorescein isothiocyanate; BD Biosciences, San Jose, California), sample lysis, wash, and resuspension in BD Perm buffer III (BD Biosciences). Samples were then washed and stained with pSTAT5‐PE or pSTAT3‐PE (BD Biosciences) and analyzed on a FACSCalibur (BD Biosciences). The percent change was calculated as a change in pSTAT3 and pSTAT5 at 1, 6, and 12 hours following drug administration divided by the baseline measurement at t = 0 for each subject multiplied by 100.
+ Open protocol
+ Expand
3

STAT3 Phosphorylation in T and B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Phosphorylation of STAT3 by CD4+ T cells and CD19+ B cells was determined by phospho-specific flow cytometry. In brief, PBMCs were stained with CD3 BV510 (Biolegend) and CD19 Pe-Cy7 (Biolegend) for 30 min at RT in the dark. Next, the cells were incubated for 30 min at 37°C with various concentrations of the humanized anti-IL-21R antibody ATR-107 (Pfizer) or isotype-matched control (IgG1-Fc, R&D systems) followed by stimulation with recombinant human IL-21 (100 ng/ml, eBioscience) or recombinant human IL-6 (100 ng/ml, PeproTech, Rocky Hill, NJ, USA) for 15 min at 37°C. Cells were fixed for 10 min with Cytofix buffer (BD Biosciences) at 37°C and permeabilized 30 min in 1 ml methanol 90% at −20°C. Next, samples were stained with CD4 BV421 (Biolegend) and pSTAT3 PE (BD Biosciences). STAT3 phosphorylation was calculated as the median fluorescence intensity.
+ Open protocol
+ Expand
4

IFN-α Induced STAT Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were surface stained with CD19, CD24, and CD38 antibodies in ice-cold PBS for 30 min, then rested for 1 hr in RPMI medium. Cells were stimulated by incubating with 10,000 U/mL exogenous IFN-α (PBL) for 1 or 5 min and then fixed with formaldehyde for 10 min at 37°C, washed with ice-cold PBS, and permeabilized with 90% ice-cold methanol for 20 min on ice. tSTAT1-PE, tSTAT3-AF647, pSTAT1-AF647, and pSTAT3-PE (BD Phosflow) were added to cells, for 1 hr at 37°C.
+ Open protocol
+ Expand
5

Measurement of STAT Phosphorylation in Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
For each subject, blood was collected by venipuncture into 2 mL sodium heparin tubes at 0, 1, 6, and 12 h post upadacitinib or tofacitinib dose. Recombinant human IL-6 (400 ng/ml), or IL-7 (400 ng/ml), (R&D Systems, Minneapolis, MN) was added to blood and incubated for 10 min at 37°C. Surface antibodies were added (CD14-APC, CD3-fluorescein isothiocyanate [FITC]; BD Biosciences, San Jose, CA) and incubated on ice for an additional 20 min. Samples were lysed (Lyse/Fix, BD Biosciences, San Jose, CA) and incubated for 10 min at 37°C. Samples were washed and stored at − 70°C. For intracellular staining, samples were thawed, washed, and resuspended in BD Perm buffer III (BD Biosciences, San Jose, CA) on ice for 30 min. Samples were washed and stained with pSTAT5-PE or pSTAT3-PE (BD Biosciences, San Jose, CA) for 60 min at room temperature and then analyzed immediately on a FACSCalibur. Geometric means were determined using FlowJo analysis software. Percent inhibition of relevant STAT phosphorylation was calculated as follows: (1-(Induction of pSTAT at 1 h – baseline pSTAT at 0 h) / (Induction of pSTAT at 0 h – baseline pSTAT at 0 h)*100.
+ Open protocol
+ Expand
6

Immunophenotyping of T Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the percentage of T cell subsets, heparin-anticoagulated whole blood were collected and stained with CD3-PerCP (BD Bioscience, New Jersey, US), CD4-FITC (BD Bioscience, New Jersey, US), CXCR5-APC (Biolegand, California, US), PD-1-PE (eBioscience, California, US), ICOS-PE (eBioscience, California, US) and CD25-APC (BD Bioscience, New Jersey, US). After fixed and permeabilized, samples were stained with FoxP3-PE (BD Bioscience, New Jersey, US), p-STAT3-PE (BD Bioscience, New Jersey, US), p-STAT5-PE (BD Bioscience, New Jersey, US) and p-STAT4-PE (BD Bioscience, New Jersey, US). After stimulation with phorbol 12-myristate 13-acetate (PMA) (50 ng/ml) (Sigma-Aldrich, US), ionomycin (1 μg/ml) (Sigma-Aldrich, US), and Golgi stop (BD Bioscience, New Jersey, US) for 5 h, the fixation and permeablication were performed. Then samples were stained with IL-21-PE (BD Bioscience, New Jersey, US). Samples were measured with FACS Canto II (BD Biosciences, New Jersey, US). Gating strategy used for the analysis of all immune parameters was shown in Additional file 1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!